Intensive Bimanual Intervention in Cerebral Palsy Children
Motor disorders related to cerebral palsy are often accompanied by sensory, cognitive, perceptive, communication and behavioural impairments. It has already been shown that intensive bimanual intervention can improve arm movement, but its impact on the spontaneous use of the most affected arm in everyday life remains t
| Condition(s) | Cerebral Palsy |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Motor disorders related to cerebral palsy are often accompanied by sensory, cognitive, perceptive, communication and behavioural impairments. It has already been shown that intensive bimanual intervention can improve arm movement, but its impact on the spontaneous use of the most affected arm in everyday life remains to be established. This project aims to understand the impacts of an intensive bimanual therapy on uni- and bi-manual motor functions as well as the spontaneous use of the most affected arm. Predictive value of neuroimaging variables will also be assessed. |
| Who can participate | Inclusion Criteria: * Having a diagnosis of cerebral palsy or spastic hemiparesis encephalopathy * Having sensorimotor deficits of one or both upper limb (spastic hemiparesis with a dominance on one side of the body; Manual Ability Classification System (MACS) level 1, 2 or 3); * Having cognitive capacities to understand and perform task of the study. Exclusion Criteria: * Presenting other significant health problem which may interfere with the requested task or with the clinical intervention; * Having Botox injection in one or both upper limbs with the 4 months prior to the intervention; * Presenting significant uncorrected visual deficits. N.B. Having a ferromagnetic implant is not an exclusion criterion, such participant will be eligible but will not perform the MRI. |
| Ages | 6 Years to 17 Years |
| Sex | All |
| Lead sponsor | Laval University |
| Locations | Québec, Canada |
| Start date | 2021-06-30 |
| NCT ID | NCT05423171 |
| Official listing | https://clinicaltrials.gov/study/NCT05423171 |